- Chart
- Upturn Summary
- Fund Details
Upturn AI Summary
Defiance Daily Target 2X Long NVO ETF(NVOX)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for NVOX
11/20/2026: NVOX (1-star) is currently NOT-A-BUY. Pass it for now.
The Defiance Daily Target 2X Long NVO ETF (NVOX) provides 2x daily leveraged exposure to the share price performance of Novo Nordisk A/S through swap agreements and derivatives. Its primary strengths lie in offering tactical traders a convenient tool for magnified daily exposure without requiring a margin account. However, it carries significant risks, including severe compounding decay over multi-day holds, a high 1.31% expense ratio, and total single-stock concentration. NVOX is strictly designed for sophisticated, active short-term market participants who closely monitor their positions and technical momentum signals.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
ETF holdings, costs, diversification, valuation, risks, and market conditions provide supporting context about the fund.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Weak fit | Leveraged daily products are built for short-term trading rather than long-term growth investing. |
| Momentum investor | Strong fit while signal remains positive | Active momentum traders can use NVOX to amplify short-term upside moves in Novo Nordisk when technical signals are favorable. |
| Value investor | Weak fit | High expense ratios and daily reset mechanisms run counter to traditional value investing principles. |
| Dividend/Income investor | Weak fit | The fund does not focus on generating income and is designed entirely for capital movement via leverage. |
| Low-risk investor | Weak fit | The 2x daily leverage objective introduces extreme volatility and risk of rapid principal loss. |
Investor Profile
Ideal Investor Profile
Sophisticated day traders or tactical short-term investors seeking amplified daily directional exposure to Novo Nordisk.
Suitability
Best suited for intraday or very short-term tactical trading rather than long-term buy-and-hold investing.
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Volatility | High | Daily compounding and 2x leverage magnify price swings significantly compared to holding the underlying stock directly. |
| Market risk | High | Adverse moves in Novo Nordisk shares directly translate to accelerated losses for the fund. |
| Concentration | High | The fund's performance is entirely tied to a single underlying security and sector. |
| Tracking/expense | Medium / high | Compounding effects over periods longer than one day can cause divergence from a straight 2x multiple of the stock's multi-day return. |
| Liquidity | Medium | While tradeable, sudden drops in trading interest can impact execution costs during volatile sessions. |
| Business/sector quality | Medium / high | The fund is vulnerable to regulatory, competitive, or clinical setbacks impacting Novo Nordisk. |
Sector & Industry Intelligence
This fund is not assigned to one sector.
Risk Analysis
Volatility
NVOX exhibits extreme historical and implied volatility due to its 2x daily leverage target on a single high-profile equity.
Market Risk
Carries concentrated single-stock risk, making it completely susceptible to adverse developments affecting Novo Nordisk A/S.
What the ETF Owns
| Exposure Type | Exposure | Weight (%) | Retail Investor Read |
|---|---|---|---|
| Single stock | Novo Nordisk A/S ADR (NVO) — seeks 2x daily return | 100 | Provides leveraged exposure to the daily price fluctuations of pharmaceutical giant Novo Nordisk through derivative contracts. |
Price Behavior

Downtrend
The stock has experienced a sustained decline in price over recent periods.

Choppy
The stock has experienced frequent reversals and pronounced short-term price swings.
Analysis of Past Performance
Type ETF | Historic Profit -44.81% | Avg. Invested days 19 | Today’s Advisory PASS |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | ETF Returns Performance |

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

